Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis

Luis Henrique Rios Moreira Rego; Vitor Kendi Tsuchiya Sano; JB Gazabon; Rommel Mário Rodríguez Burbano; Francisco Cézar Aquino de Moraes; Gustavo Tadeu Freitas Uchôa Matheus

doi:10.1080/14737140.2025.2602802

Affiliated Institutions

Related Publications

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

Catherine Roche‐Lestienne , Valérie Soenen , Nathalie Grardel +5 more

Abstract Targeting the tyrosine kinase activity ofBCR-ABL represents a very promising therapeutic strategy in chronic myeloid leukemia (CML). Despite strong efficacy of the tyro...

2002 Blood 515 citations

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

Elias Jabbour , Hagop M. Kantarjian

Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...

2014 American Journal of Hematology 210 citations

Diagnosing and Managing Advanced Chronic Myeloid Leukemia

Michael W. Deininger

Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural h...

2015 American Society of Clinical Oncology... 28 citations

Propagation of human blastic myeloid leukemias in the SCID mouse

CL Sawyers , ML Gishizky , S. Quan +2 more

Abstract Existing in vitro culture technology does not permit the routine propagation of most human myeloid leukemias. Previous work has shown the usefulness of mice with severe...

1992 Blood 98 citations

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri , Margaret von Mehren , Charles D. Blanke +18 more

Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor. Inhibition of the KIT s...

2002 New England Journal of Medicine 4336 citations

Publication Info

Year: 2025
Type: review
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Luis Henrique Rios Moreira Rego, 
                                
                                    Vitor Kendi Tsuchiya Sano, 
                                
                                    JB Gazabon
                                
                                et al.
                            
                            (2025). 
                            Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis. 
                            Expert Review of Anticancer Therapy
                            
                            .
                            https://doi.org/10.1080/14737140.2025.2602802

Identifiers

DOI: 10.1080/14737140.2025.2602802